Cancer screenings rebounded after a dramatic decline in the first months of the COVID-19 pandemic, but a new study found an increase in disparities among some screening tests during the pandemic. Dana-Farber Cancer Institute's Toni Choueiri, MD, and Chris Labaki, MD, detail the findings. Press Release: http://ms.spr.ly/6053nN0Fd